Specific immunotherapy and therapeutic strategies in allergic diseases. What's new?;Désensibilisation et nouvelles thérapeutiques. Quelles avancées?

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 7, 2005, Pages 1475-1489

  Tonnel, André Bernard ^a   Nordmann, Roger ^b   Molina, Claude ^b   Milhaud, Gérard ^b   Delaveau, Pierre ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Allergens; Asthma; Desensitization immunologic; Immune tolerance; Rhinitis

Indexed keywords

EID: 33645099412     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33457-0     Document Type: Review

References (37)

1. NORMAN P.S. - Immunotherapy 1999-2004. J. Allergy Clin. Immunol, 2004, 113, 1013-1023.
2. ADKIS C.A., BLASER K. - Mechanisms of allergen-specific immunotherapy. Allergy. 2000, 55, 522-530.
3. TILL S.J., NOURI-ARIA K., DURHAM S.R. - Mechanisms of immunotherapy. J. Allergy. Clin. Immunol., 2004, 113, 1025-1034.
4. CASALE T.B. - Status of immunotherapy: current and future (Editorial). J. Allergy. Clin. Immunol., 2004, 113, 1036-1039.
5. ADKIS C.A., BLASER K., AKDIS M. - Genes of tolerance (Review article). Allergy 2004, 59, 897-913.
6. JUTEL M., ADKIS M., BUDAK F., AEBISCHER-CASAULTA C., WRZYSZCZ M., BLASER K. - IL-10 and TGF cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol., 2003, 33, 1205-1214.
7. + T cells by grass pollen immunotherapy. J. Allergy. Clin. Immunol., 2003, 111, 1255-1261.
8. DE HEER H.J., HAMMAD H., SOULLIE T., HIJDRA D., Vos N., WILLART M.A., HOOGSTEDEN H.C., LAMBRECHT B.N. - Essential role of lung plasmocytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med., 2004, 200, 89-98.
9. ABRAMSON M.J., PUY R.M., WEINER J.M. - Immunotherapy in asthma: an updated systematic review. Allergy., 1999, 54, 1022-1041.
10. DURHAM S.R., WALKER S.M., VARGA E.M., JACOBSON M.R., O'BRIEN F., NOBLE W., TILL S.V., HAMID Q.A., NOURI-ARIA R.T. - Long term clinical efficacy of grass pollen immunotherapy. N. Engl. J. Med., 1999, 341, 468-475.
11. Di RIENZO V., MARCUCCI F., PUCINELLI P., PARMIANI S., FRATI F., LENSI L., CANONICA G.W., PASSALACQUA G. - Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy., 2003, 33, 206-210.
12. DES ROCHES A., PARADIS L., MENARDO J.L., BOUGES S., DAURES J.P., BOUSQUET J. - Immunotherapy with a standardized Dermatophagoïdes pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensibilisations in children. J. Allergy. Clin. Immunol., 1997, 99, 450-453.
13. PAJNO G.B., BARBERIO G., DE LUCA F., MORABITO L., PARMIANI S. - Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin. Exp. Allergy., 2001, 31, 1392-1397.
14. MöLLER C., DREBORG G., FERDOUSI H.A., HALKEN S., HOST A., JACOBSEN L. - Pollen immunotherapy reduces the development of asthma children with seasonal rhinoconjunctivitis (The PAT-study). J. Allergy. Clin. Immunol., 2002, 109, 251-256.
15. BOUSQUET J., LOCKEY R., MALLING H.J. - Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J. Allergy. Clin. Immunol., 1998, 102, 558-562.
16. MALLING H.J., ABREU-NOGUEIRA J., ALVAREZ-CUESTA E., BJØRSKEN B., BOUSQUET J., CAILLOT D., CANONICA G.W., PASSALACQUA G., SAXONIS-PAPAGEORGIOU P., VALOVIRTA E. - Local immunotherapy - Position paper. Allergy., 1998, 53, 933-944.
17. KHINCHI M.S., POULSEN L.K., CARAT F., ANDRE C., HANSEN A.B., MALLING H.J. - Clinical efficacy of sublingual subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double blind, double dummy study. Allergy., 2004, 59, 45-53.
18. WILSON D.R., TORRES LIMA M., DURHAM S.R. - Sublingual immunotherapy for allergic rhinitis (Cochrane review). In: The Cochrane library, Issue 2, 2003. Oxford.
19. FREW A.J., SMITH H.I. - Sublingual immunotherapy (Rostrum). J. Allergy. Clin. Immunol., 2001, 107, 441-444.
20. WILSON D.R., TORRES-LIMA M., DURHAM S.R. - Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis. Allergy, 2005, 60, 4-12.
21. GIDARO G.B., MARCUCCI F., SENSI L., INCORVAIA C., FRATI F., CIPRANDI G. - The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin. Exp. Allergy., 2005, 35, 565-571.
22. Di RIENZO V., MINELLI M., MUSARRA A., SAMBUGARO R., PECORA S., CANONINA W.G., PASSALACQUA G. - Post-marketting survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin. Exp. Allergy., 2005, 35, 560-564.
23. MORENO C., CUESTA-HERRANZ J., FERNANDEZ-TAVORA L., ALVAREZ-CUESTA E. - Immunotherapy safety: a prospective multicentric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin. Exp. Allergy., 2004, 34, 527-531.
24. NORMAN P.S., OHMAN J.L., LONG A.A., CRETICOS P.S., GEFTER M.A., SHAKED Z., WOOD R.A., EGGLESTON P.A., HAFNER K.B., RAO P., LICHTENSTEIN J.M., JONES N.H., NICODEMUS C.F. - Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care. Med., 1996, 154, 1623-1628.
25. HASELDEN B.M., KAY A.B., LARCHE M. - Immunoglobulin-E independent major histocompatibility complex-restricted T cell peptide epitopes induce late asthmatic reactions. J. Exp. Med., 1999, 189, 1885-1894.
26. RAZ E., TIGHE H., SATO Y., CORR M., DUDLER J.A., ROMAN M., SWAIN S.L., SPIEGELBERG H.L., CARSON D.A. - Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci., USA 1996, 93, 5141-5145.
27. Hsu C.H., CHUA K.Y., TAO M.H., LAI Y.L., Wu H.D., HUANG S.K., HSIEH K.H. - Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med., 1996, 2, 540-544.
28. LUDWIG-PORTUGALL I., MONTERMANN E., KREMER A., RESKE-KUNZ A.B., SUDOWE S. - Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination. J. Allergy. Clin. Immunol., 2004, 114, 951-917.
29. TIGHE H., TAKABAYASHI K., SCHWARTZ D., VAN NEST G., TUCK S., EIDEN J.J., SPIEGELBERG H.L., RAZ E. - Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy. Clin. Immunol., 2000, 106, 124-134.
30. MARSHALL J.D., ABTAHI S., EIDEN J.J., TUCK S., MILLEY R., HAYCOCK R., REID M.J., KAGEY-SOBOTKA A., CRETICOS P.S., LICHTENSTEIN L.M., VAN NEST G. - Immunostimulatory sequences DNA linked to the Amb a 1 allergen promotes T (H)1 cytokine expression while downregulating T (H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J. Allergy. Clin. Immunol., 2001, 108, 191-197.
31. SIMONS F.E.R., SHIKISHIMA Y., VAN NEST G., EIDEN J.J., HAYFLASS K.T. - Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy. Clin. Immunol., 2004, 113, 1144-1451.
32. BIET F., DUEZ C., KREMER L., MARQUILLIES P., AMNIAI L., TONNEL A.B., LOCHT C., PESTEL J. - Recombinant Mycobacterium bovis PCG producing IL-18 reduces IL-5 production and bronchoalveolar eosinophilia induced by an allergic reaction. Allergy., 2005, 60, 1065-1072.
33. DAERON M., MALBEC O., LATOUR S., AROCK M., FRIEDMAN W.H. - Regulation of high affinity IgE receptor-mediated mast cell activation by murine low affinity IgE receptors. J. Clin. Invest., 1995, 95, 577-585.
34. ZHU D., KEPLEY C.L., ZHANG K., TERADA T., YAMADA T., SAXON A. - A chimeric human-cat fusion protein blocks cat induced allergy. Nat. Med., 2005, 11, 446-449.
35. KUEHR J., BRAUBUERGER J., ZIELEN S., SCHAUER U., KAMIN W., VON BERG A., LEUPOLD W., BERGMANN K.C., ROLINCK-WERNINGHAUS C., GRÉVE M., HULTSCH T., WAHN U. and the Omolizumab Rhinitis Group. - Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J. Allergy. Clin. Immunol., 2002, 109, 274-280.
36. HOLT P.G., SLY P.D., MARTINEZ F.D., WEISS S.T., BJORKSTEN B., VON MUTIUS E., WAHN U. - Drug development strategies for asthma: in search of a new paradigm. Nat. Immunol., 2004, 5, 695-698.
37. SAXON A. - What impact will the immune tolerance network have on the future treatment of allergic diseases. Clin. Exp. Allergy., 2004, 34, 1657-1659.